Dermata Therapeutics Inc.

NASDAQ: DRMA
Share price (3/25/25): $1.35
Market cap (3/25/25): $7.331 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023

Prospectuses and Registrations Filter

Prospectus supplement

Exempt offering of securities – amended

Shelf registration

Exempt offering of securities

Exempt offering of securities

Ownership Filter

Armistice Capital, LLC

Proehl Gerald T

Intracoastal Capital, LLC

Van Hoose Kyri K.

News Filter

Notice of Delisting, Failure to Satisfy Listing Rule, or Transfer of Listing

Provides Corporate Update and Reports Year End 2024 Financial Results

Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules

Dermata and Revance Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari™ With Daxxify

Provides Corporate Update and Reports Third Quarter 2024 Financial Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Definitive proxy

Preliminary proxy

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC